WallStreetZenWallStreetZen

NASDAQ: BCYC
Bicycle Therapeutics PLC Stock Ownership - Who owns Bicycle Therapeutics?

Insider buying vs selling

Have Bicycle Therapeutics PLC insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Michael Charles Ferguson HannayCHIEF PROD SUPPLY CHAIN OFF2024-04-11257$22.49
$5.78kSell
Travis Alvin ThompsonCHIEF ACCOUNTING OFFICER2024-04-03152$23.81
$3.62kSell
Nigel CrockettCHIEF BUSINESS OFFICER2024-04-03955$23.81
$22.74kSell
Nicholas KeenCHIEF SCIENTIFIC OFFICER2024-04-03790$23.81
$18.81kSell
Kevin LeeCHIEF EXECUTIVE OFFICER2024-04-033,158$23.81
$75.19kSell
Alistair MilnesCHIEF OPERATING OFFICER2024-04-03955$23.81
$22.74kSell
Michael SkynnerCHIEF TECHNOLOGY OFFICER2024-04-03955$23.81
$22.74kSell
Nicholas KeenChief Scientific Officer2024-01-032,640$17.50
$46.20kSell
Kevin LeeChief Executive Officer2024-01-038,703$17.50
$152.30kSell
Alistair MilnesChief Operating Officer2024-01-032,643$17.50
$46.25kSell

1 of 3

BCYC insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BCYC insiders and whales buy or sell their stock.

BCYC Shareholders

What type of owners hold Bicycle Therapeutics PLC stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Baker Bros Advisors LP20.19%8,636,006$174.62MInsider
Baker Bros Advisors LP11.55%4,942,823$99.94MInstitution
Deep Track Capital LP8.16%3,490,506$70.58MInstitution
Paradigm Biocapital Advisors LP7.59%3,246,759$65.65MInstitution
Carolyn Ng4.67%1,998,580$40.41MInsider
Tybourne Capital Management Hk Ltd4.58%1,957,961$39.59MInsider
Deborah Harland4.48%1,915,275$38.73MInsider
Svlsf V LLC4.48%1,915,274$38.73MInsider
Glaxosmithkline PLC4.47%1,910,531$38.63MInsider
Kate Bingham4.46%1,910,016$38.62MInsider

1 of 3

BCYC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BCYC51.87%48.13%Net SellingNet Selling
ABCL40.83%47.36%Net BuyingNet Buying
ABVX37.14%0.00%
TYRA65.76%34.24%Net BuyingNet Buying
SLN20.95%0.00%

Bicycle Therapeutics Stock Ownership FAQ

Who owns Bicycle Therapeutics?

Bicycle Therapeutics (NASDAQ: BCYC) is owned by 71.21% institutional shareholders, 66.08% Bicycle Therapeutics insiders, and 0.00% retail investors. Baker Bros Advisors LP is the largest individual Bicycle Therapeutics shareholder, owning 8.64M shares representing 20.19% of the company. Baker Bros Advisors LP's Bicycle Therapeutics shares are currently valued at $174.62M.

If you're new to stock investing, here's how to buy Bicycle Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.